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ABSTRACT 
In this study, gelling which occurred during the processing of a peptide drug formulation 
was investigated. The formulation was prepared by dissolving the drug in a lipid vehicle, 
composed of mono-, di- and triglycerides of Caprylic (C8) and Capric (C 10) Acids 
(MCM). Gelling was observed during high shear mixing of the formulation. Therefore, 
to evaluate the gelled material, a solution of the drug in MCM was sheared at 3000 rpm 
until it turned into an opaque gel. The rheology, thermodynamic properties, chemical 
structure, polymorphism, particle size, moisture content and stability of the vehicle and 
pre- and post-sheared formulation were evaluated. The factors such as shear rate, 
temperature, time, humidity and solution concentration that may affect the development 
of a gel structure were investigated. 
While rheograms of the vehicle and the drug solurion showed i\iewtonian behavior, 
oscillatory measurements showed that there is a structure build up in the system. This 
interaction of the drug and the vehicle was postulated to occur via hydrogen bonds, and 
was shown by a Differential Scanning Calorimeter (DSC) and Fourier Transform Infrared 
(Ff-IR). 
It was determined that prolonged shearing changed the rheological behavior of the system 
from Newtonian to pseudoplastic. Shearing also caused physical modification of the 
system which was verified with Ff-IR studies and X-Ray diffraction. Gelling was found 
to be a physical phenomenon and was shown to be reversible by heating. 
II 
Shear rate, shearing time, temperature and humidity were found to be the critical 
parameters that affect the gelation of the system. Gelling also was found to be highly 
concentration dependent. As the concentration increases, zero shear viscosity of the 
solution increases. The slope of the curve of zero shear viscosity vs. concentration 
changes sharply at a concentration above 17% (w/v) at which gelling starts. At a 
concentration of 15% (w/v) and below, a gel structure did not form. In addition, 
appearance of particles above l nm starts at 10% (w/v) concentration and the particle size 
increases as the concentration increases. DSC studies of the different solution 
concentrations suggest that the drug at increased concentrations interacts with a vehicle 
component. The solution reaches saturation at a concentration of 17% (w/v), and 
addition of the drug beyond this level may increase particle formation which acts as gel 
nuclei by interaction of the drug with vehicle components. Particle size increases at 40°C 
and disappears at 80°C. These temperature sensitive particles may cause phase transition 
upon shearing. 
In order to avoid this gelling phenomenon during processing of the formulation of the 
drug, the vehicle components should be thoroughly characterized. The use of high shear 
should be avoided. If possible, all processing should be conducted at or above 60°C at 
low humidity levels. 
lll 
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PREFACE 
A model peptide drug is formulated as a lipid solution and encapsulated in soft-gel 
capsules. The drug has poor bioavailability and low aqueous solubility (0.03 mg/mL). It 
is a highly lipophilic drug with two pKas (pKa1 = 1.1 and pKa2 =7.1) and with a partition 
coefficient of 3.34. The number of solvents that increase the solubility of the drug is very 
limited. Mono- di- and triglyceride of capric and caprylic acids (MCM) was selected for 
formulation development because of its suitable solvent properties. The final formulation 
contains 20% active substance in MCM. In preparing the formulation. the vehicle is 
heated and the drug is then added and stirred using a high shear mixer until a clear 
solution is obtained. The solution is cooled to 25°C. The formulation is encapsulated 
into soft-gel capsules at room temperature. 
In order to improve patient compliance, the reduction of number of dosing units to be 
administrated is always desirable. This can be achieved by increasing the drug loading in 
the vehicle and thus reducing the number of capsules to be administrated. However, 
higher drug loading is extremely challenging because of the occurrence of gelling during 
processing. 
It was observed that during processing. the formulation had a tendency to gel due to high 
shear mixing. Gelation can reduce the dissolution rate of the drug from the capsule, 
although it appears that gelling does not have a significant effect on drug bioavailability. 
However, during processing, the capsule fill formulation should remain as a solution and 
v 
preferably stay as such in the soft-gel capsule throughout the product shelf life. Gelation 
can also change the appearance of the formulation. In order to resolve this situation, 
complete characterization of the gelling mechanism and the formulation is necessary. 
This study characterizes the changes occurred which in the formulation and suggests a 
potential solution to minimize or overcome the gelling. 
Vi 
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I. INTRODUCTION 
1.1 OVERVIEW OF THE DRUG 
The drug used in this study is a peptide analogue and is used as a model drug to 
investigate the gelling phenomenon in a lipid vehicle. 
The drug { N-tert-butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[ N-(2-
quinolylcarbonyl)-L-asparagynyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide 
(DQAIC)} is a transition-state mimetic of the phenylalanine-proline (Phe-Pro) peptide 
cleavage site. 
1.2. PHYSICAL CHEMICAL PROPERTIES AND DESCRIPTION OF DQA~C: 
DQAIC is a white, amorphous, micronized powder. It has a molecular weight of 670.86. 
DQAIC has poor aqueous solubility (0.03 mg/ml). It is soluble in ethanol, propylene 
glycol and some lipid vehicles. It is a highly lipophilic drug with two pKas (pKa1= 1.1 
and pKa2 =7.1) and with a partition coefficient of 3.34. The melting range is 123 .3°-
124.6°C. 
1.3 RA TIO NALE FOR DEVELOPING SOFT GEL CAPSULE FORMULATION 
Due to lipophilic properties of the drug (log P =3.34) and its limited solubility in the 
common solvents, Table I, an oil based solvent that would provide good solvent 
properties like MCM, a medium chain fatty acid ester was chosen that dissolve DQAIC 
with 400 mg/mL solubility value and the solution can encapsulated. 
Since the bioavailability of the drug is dissolution dependent, its solubility needs 
improvement. Several approaches were tested to improve its bioavailability. Salts of 
DQAIC were prepared which did not provide the required bioavailability. Micellar 
solubilization with Tween, Brij and Pluronic provided small improvements in solubility. 
Solid dispersions of the drug did not offer better dissolution due to poor drug loading. 
Enteric coated tablets did not provide adequate bioavailability. 
Based on solubilization data, Table I, lipid based solvents were proposed as the 
reasonable vehicle to achieve a satisfactory formulation. 
DQAIC due to its lipophilic character (log P= 3.34) dissolves in oil fractions and 
mixtures to a reasonable degree. MCM, mixture of mono- . di- and triglyceride. was used 
as the solvent due to its suitable solvent properties. 
2 
Table I : Solubility of DQAIC in Various Solvents at 21°C 
Solvent 
Ethanol 
Water 
Glycerol 
Propylene Glycol 
Mono- I di-glycerides of capric/ caprylic acids 
PEG-6 caprylic and capric glycerides 
Glycerol monocaprylate 
Triglyceride of capric and caprylic acid 
3 
Solubility (mg/mL) 
400 
0.03 
< 1 
400 
400 
400 
388 
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1.4. STA TEl\.'IENT OF THE PROBLEM 
The selected formulation contains 20% (w/w) drug, dissolved in MCM (mixture of mono-
di- and triglyceride of caprylic and capric acids). The formulation is a viscous solution 
with Newtonian properties. 
The formulation is prepared as follow: 
The processing unit includes a jacketed vessel, a mixer and a temperature regulator. The 
vehicle is then heated up to 65°C, the drug is added and the contents are thoroughly 
mixed until a clear solution is obtained by using high shear mixer. The liquid 
formulation is cooled down to room temperature, and encapsulated into soft-gel capsules. 
During processing of DQAIC soft-gels, some formulations turn into a translucent mi; ~ure 
from a transparent clear solution. Former investigations demonstrated that the shearing 
stress applied during the mixing and encapsulation stages were responsible for these 
changes that occurred. The gelling tendency was observed to be more pronounced in the 
high shear mixing. 
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1.5 OVERVIEW OF ANALYTICAL METHODS USED TO CHARACTERIZE 
GELLING 
1.5.1 Rheological Investigations 
Rheology is the study of the flow and deformation of materials. Studying rheology will 
be extremely beneficial for characterization of fluids and semi solids specially when other 
properties such as molecular weight can also be well defined. The rheology of a particular 
product, which can range in consistency from liquid to solid, drug dissolution, physical 
stability and even bioavailability. In this case. rheological measurements will provide 
important information about effects of processing factors. 
Rheological measurements can be carried out either by measuring flow properties under 
continue shear or oscillatory disturbance. Continuous shear measurements provide 
information about apparent yield stress, viscosity, shear thinning and thixotropic behavior 
and good correlation with real processes such as pumping, stirring and extrusion through 
a nozzle. However, continuous shear during flow measurements alters a material's 
ground state. On the other hand, oscillatory measurement is designed not to destroy the 
structure, so that these measurements can provide information on the intermolecular and 
interparticle forces of the material and measures both viscous and elastic behavior of a 
sample. The stress or shear rate is applied in a sinusoidal manner and hence the sample is 
simple "wobbled". In oscillation measurements, it is important to find the viscoelastic 
linear region since it is a non-destructive test. In oscillatory tests, the elastic (G') and 
5 
viscous moduli (G") and the complex viscosity (TJ*) are determined. G" represents 
viscous dissipation or loss of energy while G' elastic storage of energy. The more 
viscous the system, the more differences between the shear stress (input) and shear rate 
(output) will be observed. This differences is defined as delta (o) which is related to 
elastic to viscous modulus by: 
tan (o) = G"/G' .................................................................................................................. ( 1) 
where G' is elastic modulus and G" is viscous modulus. Their relationship to complex 
viscosity is demonstrated as: 
T]* = (G' + iG")/w ........................................................................ ...................................... (2) 
where w is angular frequency and i is imaginary root. 
The phase angle ( o) indicates the elastic strength of the body. It changes from 0 to 90. At 
low values, the system is elastic at high values it is viscous ( 1, 2, 3). 
Strain sweep, frequency sweep and temperature sweep are important experiments to be 
carried out. Strain is relative deformation to the initial length of material. Strain sweep is 
important to predict the strength of a samples internal structure. Frequency sweep is used 
to differentiate flow properties and structural differences. In oscillatory measurements, 
creep test can be carried out , which measures the slow deformation of a material under a 
small constant stress. In a creep test, retardation of the material is initially measured 
under constant stress, and then relaxation is measured by removing the stress and the 
material behavior is defined. 
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1.5.2 Thermoanalysis 
Thermal analysis is useful to characterize materials and in this case may indicate the 
changes in the form. Determination of glass transition temperature (T g) which 
characterizes the amorphous phase, melting points (Tm) and crystallization points provide 
an identification of the stability of the gels obtained. A Differential Scanning Calorimeter 
was used for thermodynamic characterization of the system. One of the most classical 
application of DSC is in the determination of possible interactions between a drug and the 
excipients in its formulation. In DSC technique, heat flow into a substance and reference 
are measured as a function of sample temperature while the two are subjected to a 
controlled temperature program. 
At T g, the heat capacity of the sample suddenly increases, requiring more power to 
maintain the same temperature as the reference temperature. This differential heat flow 
to the sample (endothermic) causes a drop in the DSC curve. At Tm' the sample crystals 
want to melt at a constant temperature, so that a sudden input of large amounts of heat is 
required to keep the sample temperature the same the reference temperature. This results 
in a characteristic endothermic melting peak. Crystallization, in which large amounts of 
heat are given off at constant temperature, gives an exothermic peak. 
Glass transition is defined as the temperature at which the heat capacity is midway 
between the liquid and glassy states. Determination of the Tg of a material is important 
7 
since it characterizes the amorphous phase which has improved dissolution rates and 
bioavailability over the crystalline state (1, 4 ). 
1.5.3 FT-IR and Raman Analysis 
In order to understand whether the changes occumng m the system are chemical or 
physico-chemical in nature and the type of interaction between the vehicle and the drug 
molecules, Ff-IR equipped with Raman accessory can be useful. In IR technique, a 
molecule must undergo a net change in dipole moment as a consequence of its vibrational 
or rotational motion in order to absorb infrared radiation. The types of molecular 
vibrations are stretching and bending. A stretching vibration involves a continues change 
in the interatornic distance along the axis of bond between the two atoms. Bending 
vibrations are characterized by a change in the angle between the two bonds and are of 
four types: scissoring, rocking, wagging and twisting. Ff-IR technique has three major 
advantages over regular IR techniques. First advantage is called Jaquinot advantage 
where the power of the radiation reaching the detector is much greater than conventional 
dispersive IR spectrophotometer, and much greater signal-to-noise ratios are observed 
which improves certainty of the structural conformation. The second advantage of Ff-IR 
instruments is their high wavelength accuracy and precision. This leads to improved 
signal-to-noise ratios. The third advantage is called the multiplex or Fellgett advantage, 
where all the elements of the source reach the detector in a few nanoseconds to provide 
fast accurate results (5, 6). 
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In Raman Spectroscopy, the radiation is scattered as the result of vibrational-energy-level 
transitions occurring in the molecule as a consequence of the polarization process. 
Therefore, this technique is complementary to the infrared spectroscopy technique. The 
intensity of a normal Raman peak depends on polarizability of the molecule, the intensity 
of the source, and the concentration of the active groups. 
1.5.4 X-Ray Diffraction 
Polymorphism is one of the important factors that affect solubility of a drug in a 
particular solvent. Different polymorphs may exhibit different solubilities. For poorly 
soluble drugs, among others, polymorphism may affect the rate of solidification and 
dissolution. X-Ray diffraction is used to determine any polymorphic changes that may 
occur in the systems studied. 
X-Rays are electromagnetic radiation of short wavelength and therefore high energy. X-
Rays used for diffraction studies have wavelengths in the 0.1- l A range. Like all 
electromagnetic radiations, X-Rays are absorbed, scattered, and diffracted by matter. The 
scattering and diffraction X-Rays is caused by the interaction with electrons. Electrons of 
the molecules in gases, liquids, or disordered solids states scatter X-Rays. However, 
electrons in the ordered arrays of atoms in crystals scatter X-Rays only in particular 
9 
directions. Diffraction is the scattering of X-Rays in a few specific directions by the 
crystals . 
When an X-Ray beam hits a crystal surface at angle 0, a portion of it is scattered by the 
layers of atoms at the surface. The unscattered portion of the beam penetrates to the 
second layer of atoms where again a fraction is scattered, and the remainder passes on to 
the third layer (Figure 1). X-Rays appear to be reflected from the crystals only if the 
angle of incidence satisfies the following condition: 
Sin0 = n/J2d ...................................................................................................................... (3) 
where n is order of reflection (an integer), /.... is wavelength of X-Rays source, d is the 
interplanar spacing of the crystal. This equation is called Bragg Equation. and is used to 
determined value of crystals (6). 
10 
R 
Figure 1: Diffraction of X-Rays by a Crystal 
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1.5 .5 Dynamic Light Scattering 
In Dynamic Light Scattering (DLS), the temporal variation of the intensity is measured. 
Diffusion coefficients of the particles, particle size, and size distribution can be obtained 
from such measurements. A DLS apparatus contains a laser light source, a spectrometer 
(containing the optical components for defining the scattering angle volume), a detector. a 
correlator and a computer with software for analysis. A schematic representation of a 
typical arrangement is shown in Figure 2. 
Once the diffusion coefficient of a the particle is found, the particle size can be calculated 
from the Stokes-Einstein equation 
D =(ks T)/(6 rr Tl RH) .................................................................................................... ... (4) 
where Tl is the viscosity of the fluid, ks is the Boltzman constant, and T is the absolute 
temperature of the system. The radius RH measured in this manner is usually known as 
the hydrodynamic radius (7). 
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Figure 2: Schematic View of a Typical Light Scattering Instrument 
II. OBJECTIVES 
The formulation under investigation is a relatively high concentration drug solution in 
MCM encapsulated in soft-gel capsules. Occasional gelation occurs during processing of 
the dosage form making high drug loading a difficult process. The occurrence of gelation 
can potentially reduce dissolution rate of the drug. Ideally, during processing, the capsule 
fill formulation should remain as a solution and preferable stay as a liquid through the 
product shelf-life. Gelation can also change the appearance of the formulation. 
In order to come up with an acceptable remedy to gelling, full characterization of the 
system is necessary. The aim of this study is to characterize the shear, temperature and 
concentration dependent changes occurring in the system during processmg. 
Determination and characterization of the rheological, thermoanalytical and chemical 
changes that occur in the system by aforementioned variables is the main goal of this 
study. Combined effects of the factors such as the shear, temperature, time and humidity 
that may have an effect on the processing of the formulation will also be determined in 
order to explain gelling phenomenon. 
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III.EXPERIMENTAL 
3.1 MATERIALS USED 
All the main chemicals used in this study are listed in Table II. The properties of the drug 
used has been already described in Section 1.2. and MCM, used as the vehicle, in Section 
3.1.1. 
3.1.1 The Vehicle 
MCM was used as the solvent in soft-gel fonnulation . The reasons for its selection were 
discussed in Sections 1.3 and 1.4. MCM is mixture of mono-, di- and triglyceride of 
dominantly caprylic (C8) and capric (C 10) acids. It has an approximate molecular weight 
of 250. The specifications of MCM are given in Table Ill (8). 
MCM is processed by the reaction of glycerin or propylene glycol with fatty acids 
obtained from palm, kernel and coconut oils in the presence of an alkaline catalyst. The 
products are further purified to obtain a mixture of glycerides, free fatty acids, free 
glycerin that contains at least 90 % by-weight glycerides. The ingredients meet the 
specifications of the Food Chemical Codex, 3d Ed. ( 1981 ), p 20 l. The affinnation of this 
ingredient is generally recognized as safe (GRAS) (9). 
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Table II: List of Chemicals Used 
CHEMICALS 
DQAIC 
MCM (mono- di and triglyceride 
of Caprylic and Capric Acid) 
MCM D (mono- di and 
triglyceride of Caprylic and Capric 
Acid) 
PG-8 (Propylene glycol ester of 
Caprylic and Capric Acid) 
Polyvinyl Pyrrolidone K30 
Propylene Glycol 
Monoglyceride of Caprylic Acid 
Diglyceride of Caprylic Acid 
Triglyceride of Caprylic Acid 
Karl Fisher Reagent 
(Diethylene glycol monoethyl 
ether, imidazole, sulfur dioxide, 
iodine, hydriodic acid ) 
LOT NO. 
60111-6 
JLW-6l-25B 
80205 
960026 
20-652-930185 
041H8431 
010H84466 
038H0651 
70990 
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~IANUF ACTURES 
Abitec Corp. 
Columbus, OH 43216 
Abitec Corp. 
Columbus, OH 43216 
Abitec Corp. 
Columbus, OH 43216 
BASF Corp .. Mount Olive, NJ 
Dow Chemical, Midland, MI 
Sigma-Aldrich, Inc., Saint Louis, MO 
Sigma-Aldrich, Inc., Saint Louis, MO 
Sigma-Aldrich, Inc., Saint Louis, MO 
Allied Signal Inc., Morristown, NJ 
Table III : Specifications of MCM As Provided by the Manufacturer 
Test 
Acid value (mg KOH/g sample) 
Color 
Free glycerol 
Water content 
Sulfated Ash 
Hydroxyl value 
Iodine value 
Saponification value 
Density at 30°C 
Viscosity at 30°C 
HLB 
Glyceride composition 
Mono glyceride 
Di glyceride 
Triglyceride 
Alkyl chain distribution (%) 
Test Result 
<4 
3.2R 
0.86 % 
0.34 % 
0.28 % 
386 
0.1 
277 
0.995 g/mL 
64.6 cS 
5.5 
68.57% 
25.95% 
2.65% 
C6 (Caproic acid) 0.6 
Cs (Caprylic acid) 86.1 
CIO(Capric acid) 13.3 
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Method 
USP 
AOCS Cc 13b-45 
NF 
USP 
EP 
USP 
EP 
USP 
MCM is a mixture of mono-, di- and triglyceride but mainly composed of monoglyceride, 
and is semisolid at ambient temperature. Its melting point is not specified and the final 
melting behavior is dependent on thermal pre-history and therefore it should be heated 
before use to obtain liquid. It was reported that the final melting point is also dependent 
on the grade of MCM. The grades used had a low acid glycerin values. Same MCM lot 
was used throughout the study. In addition to MCM, two more grades containing 
different ratios of ester components were used for comparisons. The one that contains 85 
% mono-ester type is MCM(D) with a HLB value of 6.5, and the one with 90 % mono-
ester is PG-8 with a HLB value of 2.5, which is propylene glycol esters of C8-C 10 fatty 
acids. They were used as controls to test their impact on the gelling phenomenon 
investigated. 
3.2 INSTRUMENT USED 
The instruments used in this study are listed in Table IV. 
3.3 METHODOLOGY 
3.3.1 Preparation of the Formulation 
In this study, a laboratory scale procedure to simulate processing conditions was set up. 
All the formulations except the ones that were used to investigate the effect of 
concentration were prepared by the following method. A water jacketed glass vessel (500 
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Table IV: Instruments Used in This Study 
Instruments 
Silverson Homogenizer 
Caframo Mixer 
Temperature Regulator 
Rheometer 
Differential Scanning 
Calorimeter 
Fourier Transform Infrared 
Spectroscopy 
Zeiss Polarizing Microscope 
Scintag 2000XDS X-Ray 
Diffractometer 
Dynamic Light Scattering 
Mettler Balance 
Mettler Electronic Balance 
Model 
L4R 
RZR 2000 
9110 
Manufactures 
Silverson Machines Ltd., 
England 
Caframo Co., Canada 
Fisher Scientific, Pittsburgh, 
PA 
Carry-Med CSL 100 TA Ins., New Castle, DE 
Sil5200 Seiko Inc., Paramus, NJ 
FTS-60 A 
Axioplan 
ASC0012 
BI 200SM 
PM480 
MTS SNR P33594 
FNR 211000165 04 
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Biorad Digilab, Cambridge, 
MA 
Carl Zeiss Inc., Thomwood, 
NY 
Scintag Inc., Cupertino, CA 
Brookhaven Instrumens Corp., 
Holtsville, NY 
Mettler-Toledo Inc. , 
Hightstown, NJ 
Mettler-Toledo Inc., 
Hightstown, NJ 
Table IV (continuation) 
Instrument 
Moisture Analyzer 
Incubator 
Environmental Chamber 
Incubator 
Refrigerator 
Model Manufacturer 
Blending Karl Fisher Orion Research Inc., Boston, MA 
Turbo2 Co-10 
3940 
3852 
3920 
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Forma Scientific Inc., Marietta, OH 
Forma Scientific Inc., Marietta. OH 
Forma Scientific Inc., Marietta, OH 
Fisher Scientific, Springfield, NJ 
mL) was used for all sample preparations. The vehicle ( 400g) is weighted and transferred 
into the vessel connected with a temperature regulator. The vehicle was heated to 65°C. 
DQAIC (I 00 g) was added to the heated vehicle and mixed for 30 minutes at 3000 rpm 
using a Silverson L4R homogenizer that provided turbulent mixing until the drug was 
completely dissolved. The formulation was cooled down to 25°C at a cooling rate of 
20°C /hour. 
The formulation prepared was subjected to shear at 3000 rpm, 25°C until it was reverted 
to an opaque gel. To analyze the effect of shearing time, 20 g samples were withdrawn 
every 3 hours during shearing. 
The same procedure was followed for the vehicle and all other sample preparations. The 
formulation was sheared at varying temperatures (-+Jc, 6\f, 80,)C), shear rates (I 500, 5CO 
rpm) and humidity environments (50 and 30 % Relative Humidity). All experiments 
were carried out in triplicates. 
The effect of drug concentrations investigated using the method described below: The 
vehicle (200mL) was heated up to 65°C, and the drug at various concentrations (2, 5, 7, 
10, 12, 15, 17, 20, 22, 25% w/v) was added and mixed using a Caframo RZR '.?.000 mixer 
that provides impeller type mixing until the drug was completely dissolved. The mixer 
was changed to impeller type mixer because turbulent mixer was inoperable at high drug 
concentrations. The solution was cooled to 25°C at a cooling rate of 20°C /hour, and the 
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solution was transferred to a 250 mL volumetric flask and added up to final volume with 
MCM, heated up to 65°C for 30 minutes and cooled down to ambient temperature before 
used. 
3.3.2 Characterization of the Drug, Vehicle and the Formulation 
3.3.2. l Rheological Investigations 
A Carri-Med CSL I 00 Rheometer (TA Ins, New Castle, DE) is used for the rheological 
investigations. A cone and plate geometry for flow modes and a parallel plate geometry 
for oscillatory and creep measurements were chosen as the best modes to detect shear-
dependent structural changes occurring in the system. The flow mode was investigated 
by using a 4 cm 12 degree cone and plate with a 0.053 mm gap. These arrangements were 
tested at 1-500 I/sec shear rate. I 0 % significance tolerance was selected to obtain per 
data point. The creep mode was studied by using a 6 cm parallel plate with I mm gap. 
0.5 dyne/cm2 shear stress was applied to the system. It was sheared for 3 minutes and 
relaxed by omitting stress applied for 3 minutes. The oscillatory studies were conducted 
by the same parallel plate with I mm gap. The linear region was obtained in 0.1-10 strain 
range at 0.5 Hz frequency. Frequency sweep was carried out in a range of 0.1-0.5 Hz at I 
strain. 4-80°C temperature range, 0.5 Hz frequency and I strain was used in temperature 
sweeps. All experiments except temperature sweep was conducted at 25°C. Temperature 
sweep was conducted over a temperature range of 4-80°C with a 6 cm parallel plate and l 
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mm gap. This temperature range was selected in order to mimic processing and storage 
conditions. 
All the samples were tested for rheology within 3 days following preparation. The 
samples were equilibrated at 25°C for 20 minutes prior to rheological measurements. 
3.3.2.2. Thermal Analysis 
In order to follow the thermodynamic changes that occur in the system during shear, 
thermal analysis was conducted. A Differential Scanning Calorimeter (SII5200 DSC, 
Seiko Inc., Paramus, NJ) was used for thermodynamic characterization of the system. 
The sample to be tested ( l 0.000± 0.050 mg) was placed into a DSC pan. The pan was 
crimped with the instrument sealer for the solid samples, left uncrimped for liquid and 
semisolid samples. The preliminary runs at rates of 2, 5, 10°C/min showed the best rate 
was at 5°C/min. The vehicle and drug solution were heated and cooled in two different 
temperature ranges. First, they are heated from 20°C to 65°C at a rate of 0.33°C/min in 
order to follow thermodynamic changes during the production of the formulation. After 
holding 30 minutes at 65°C, the sample was cooled to 20°C at the same rate. The 
polymorphic reverses were investigated 3 heating and the cooling cycles between -70°C 
and 150°C at a rate of 5°C/min. A Seiko Inc., SSC 5200 disk station was used to collect 
and analyze the raw data. 
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In the thermoanalysis of the drug, the sample was placed into a DSC pan and crimped by 
the instrument sealer. The sample was heated from 20°C to 150°C at a rate of 5°C/min 
and cooled to 20°C at same rate. 
3.3.2.3 Chemical Analysis 
In order to understand further whether the changes occurring in the system are chemical 
or physico-chemical in nature and the type of interaction between the vehicle and the drug 
molecules, the samples were examined by Fourier Transform Infrared (Ff-IR, Biorad-
Digilab) equipped with Ff-Raman accessory (FfS-60). 
IR spectra was recorded at 4 cm- 1 resolution with 64 scans. Raman spectra was generated 
on the same instrument. All samples were run as they were without sample preparation. 
The laser used to illuminate the samples was a Neodymium-Yttrium Aluminum Gamet 
(Nd-Y AG) laser operating at 9395 cm- 1• A 900 mW power was used to run the samples. 
No thermal degradation was observed during measurements. 128 scans were collected at 
4 cm- 1 resolution. 
To investigate the interaction between the drug and the vehicle induced by shear, the 
spectra of the drug, the vehicle and the formulations before and after shear were obtained 
using Ff-IR, equipped with Raman spectroscopy. 
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3.3.2.4 Morphological Analyses 
In order to determine any polymorphic changes that may occur in the systems, 
microscopical and X-ray diffraction analysis were conducted at each stage of the 
formulation. 
In this study, a Scintag 2000XDS X-ray Diffractometer, ASC0012 (Scintag Inc .. 
Cupertino, CA) was used to obtain X-rays diffraction pattern of the drug, vehicle and 
solution before and after shearing. All samples were placed on a zero background plate, 
irradiated with X-rays from a copper target (A= 1.54 A ) and analyzed by X-ray powder 
diffraction from 0-45 degrees 28 at 19 ± 2°C. 
Microscopical analysis was also conducted. A Zeiss Polarizing Microscopy (Carl Zeiss 
Inc., Thomwood, NY) was used to determine any crystal growth or change of crystalline 
state or liquid crystal formation. The samples were placed onto a microscope slide and 
observed with a microscope cover with 20x 25 magnification at 19 ± 2°C. 
3.3.2.5 Particle Size Determination 
The presence of particles and the particle size changes of the solution at different 
concentrations was measured. A Dynamic Light Scattering (DLS) Apparatus BI 200MS 
(Brookhaven Instruments Corp., Holtsville, NY) was used for this purpose. 
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A Lexer Model 95 Argon Ion Laser source was used. The intensity measurements were 
obtained at 90° at 488 nm wavelength and with 200 µm hole size. The sample in a 
scintillation vial was placed in the cell holder, which was controlled at 25° ± 0.1 °C. 
Laser power was set in a manner to provide the measured intensity of approximately 70 
Kcount/sec. Delay time was adjusted according to the size of the sample. First, a 
polystyrene dispersion, which has standard particle size of 96 ± 3 nm, was used to check 
the instrumental setup. An average of three measurements were provided particle size of 
95 ± 3 nm. In order to calculate the particle size of a sample from the diffusion 
coefficient, zero shear viscosity should be known. Complex viscosity (Tl*) values from 
frequency sweep at low frequency range (0.01 - 1 Hz) can be accepted as zero-shear 
viscosity. Therefore, a frequency sweep was carried for each sample and ri* values were 
determined before the DLS measurements. 
3.3.2.6. Effect of Storage Time Measurements 
The formulations tested were kept at 25°C 60% relative humidity, 25°C with 40% 
relative humidity, 50°C with 13% RH and 4°C with ambient humidity for 4 weeks in 
scintillation vials and their rheological properties were determined at 25°C every week. 
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3.3.2.7. Measurement of the Moisture Content 
The USP Method I (Direct Titration) technique was used to determine the water content 
of the drug, MCM and the solution before and after shearing in order to determine the 
effect of water content on the gelling properties of the system. The principle of the 
titrimetric determination of water is based on the quantitative reaction of water with an 
anhydrous solution of sulfur dioxide and iodine in the presence of a buffer that reacts with 
hydrogen ions. In the original titrimetric solution, known as Karl Fisher Reagent, the 
sulfur dioxide and iodine are dissolved in pyridine and methanol ( 10). 
A Karl Fisher Moisture Titrator, model Turbo2 Co-I 0 (Orion Research Inc., Boston, MA) 
was used for this purpose. 1.000 ± 0.150 g sample was dissolved in anhydrous methanol 
solution, which was stirred for about 2 minutes and titrated with the reagent. The 
instrument calculates the water content in % w/w. 
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IV. RESULTS AND DISCUSSION 
4.1. CHARACTERIZATION OF MCM 
MCM is the mixture of mono- , di- and triglyceride of caprylic and capric acids. All 
known properties of MCM is discussed in Section 3.1. l. In order to understand gelling 
mechanism of the system, a placebo solution of only MCM was prepared under the same 
conditions used for the formulation preparation, and subjected to shear as explained in 
Section 3.3.1. 
MCM did not show any detectable structures under regular and polarized light 
microscope before and after shearing at 3000 rpm for 3, 6, 9, 12 hours. 
Data presented in Figure 3 demonstrates that MCM showed Newtonian characteristics 
having a viscosity of 83 cP at 25°C. When it contains 20% (w/w) drug, the viscosity 
increases 5-fold (411 cP). However, Newtonian characteristics remains the same with 
0.1-500 l/sec shear rate range. No thixotropic properties were detected in time dependent 
shear studies. 
On the other hand, the frequency sweep of the solvent at the linear region demonstrated 
that there is a slight structural build-up of MCM above frequencies of 0.35 Hz, which 
may indicate a very weak dilatant behavior that G" demonstrates (Figure 4). The 
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rheological properties of the drug solution shown in Figure 3-5 will be discussed in 4.3.1. 
The temperature effect on the rheology is demonstrated in Figure 5. During heating from 
4°C to 80°C, the G" is reduced from 7.75 dyne/cm2 to 0.3 dyne/cm2 between 4°C to 40°C 
and disappeared above 50°C. This may be liquefaction of the monoglyceride that tend to 
be at semisolid form at the ambient temperature. 
Figure 6 demonstrates that the DSC curves of MCM provided thermodynamic changes. 
Two different temperature ranges were used. First. the sample was heated up from 25°C 
to 65°C at a rate of 0.33°C/min, after holding the sample at 65°C for 30 min., it was 
cooled down to 25°C at the same rate (Figure 6). The intention was to imitate processing 
conditions during which MCM is heated up to 65°C and mixed with the drug for 30 min 
and cooled down to 25°C. Under these conditions, no changes were detected in MCM. 
In a second set of experiments, MCM was cooled from 20°C to -70°C, was kept at this 
temperature for l 0 minutes to equilibrate the targeted temperature, and was reheated up to 
l 50°C and cooled down to -70°C at a rate of 5°C/min. This heating and cooling cycle 
was repeated 3 times to obtain an amorphous history of the material. In order to 
determine if any thermodynamic changes may occur during shear, this procedure was 
repeated for sheared MCM as well. All the exothermic and endothermic traces were 
collected using the instrument software and related enthalpies were calculated. Figure 7 
A and B are examples of the heating and cooling performance of MCM. Their DSC 
were compared with the pure glyceride of Caprylic acid, Figure 8 A, B, C. Only 
Diglyceride has a crystallization peak. 
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The sharp melting peak of monoglyceride is at 42.66°C, diglyceride at 11.4 °C and 
triglyceride is at -48.43°C. Comparison of Figures 7 A, B and 8 A, B. C reveals the fact 
that the first peak that appear in 7 A, the wide endothermic melting may be of triglyceride 
Caprylic and Capric Acids. 
MCM was further heated to l 50°C and cooled down to -70°C. The enthalpies calculated 
are given in Table V and Table VI. The first peak appeared at -24.25°C is the triglyceride 
of Caprylic and Capric Acids, at the third heating cycle, the melting peak of the 
triglyceride esters was shifted from -25.5°C to -23.92°C. There is little differences in 6H 
during cycle experiments. The second peak which occurs at -18.63°C is an exothermic 
crystallization trace of di-ester components of the vehicle. During the heating curves, the 
6H value has changed from -35.2 to -40.4 ml/mg (Table V). The third trace is 1f-JP 
endothermic melting point of diglyceride component of MCM. The final trace is the 
melting point of monoglyceride component of the vehicle. There is a significant change, 
in 6H value of the fourth peak which differs from the other traces. The value is 
decreased from 42.0 ml/mg to 30.1 ml/mg. This decreasing in value of 6H can be 
explained by thermal decomposition of the sample. Heating may increase decomposition 
of the sample resulting in enthalpy changes. 
Only one exothermic peak was seen during the cooling of the sample. There is no 
differences in temperature and 6H values while heat flow values is increasing from 8242 
µW to 8508 µW. Since heat flow value is an instrumental parameter, this may not be a 
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Table V: DSC Traces of MCM in Temperature Range of (-70°)-(150°}C During 
Heating 
First Heating Second Heating Third Heating 
Peak* Temp. (°C} AffmJ/mg Temp. (°C) LiHmJ/mg Temp. (°C) LiHmJ/mg 
-25.50 17 .1 -24.25 15 .5 -23.92 16.9 
JS -26.14 11.6 -22.70 11.7 -22.06 9.5 
,., 
-19.87 -35.2 -18.63 -44.0 -18.29 -40.4 
2S -21.12 -43.0 -17.65 -41.4 -17.06 -41.7 
3 -0.74 11.0 -1.37 8.0 -0.78 10.5 
3S -1.08 18.2 -0.74 9.4 -0.12 9.9 
4 21.80 42.0 21 .79 33.0 22.12 30.1 
4S 18.65 43.9 23.36 30.6 23.04 28.2 
----
* the peak denoted S in italic form are for the sheared MCM samples 
Table VI: DSC Trace of MCM in Temperature Range of (-70°)-(150°) C During 
Cooling 
Temperature (0 C) LiH (mJ/mg) 
First Cooling -30.89 -53.2 
First Cooling -28.99 -51.9 
Second Cooling -30.54 -53.1 
Second Cooling -28.69 -51.l 
Third Cooling -30.54 -53.3 
Third Cooling -29.01 -48.9 
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sign of thermodynamic changes occurred in the sample. The cooling curves on the other 
hand, do not show a temperature dependent transformation between the fatty acid 
glycerides. 
Overall, DSC results of MCM show that the vehicle is not thermostable. 
DSC results for the sheared vehicle showed that shearing did not caused any significant 
effect on the thermodynamics of MCM (Table V). Although, there are differences in the 
location of the melting peaks caused by the first and second heating, these may be due to 
moisture uptake induced by shear which disappears after first heating. 
Figure 9 demonstrates FT-IR of MCM. The broad band which appeared at 3410 cm· 1 is 
the hydrogen bond (0-H) stretching. The sharp bands between 2957-2858 cm·' 
corresponds to alkane (C-H) stretching. Carboxylic acid ester stretching can be seen at 
1741 cm- 1• The bands at between 1470 and 1200 cm- 1 correspond for C-H and 0-H 
bending. C-0-C stretching can be seen at between 1300 and 1050 cm- 1• 
Raman spectrum was obtained on same instrument in order to get completed information 
about the chemical structure of MCM, Figure 10. The stretching vibrations at between 
2800 and 2940 cm- 1 are for -CH- groups. The small and weak peak at 1744 cm- 1 
corresponds for C=O groups. A -CH2 bending vibration and CH3 antisymmetric vibration 
can be seen at 1445 cm- 1 • The peak at 1308 cm- 1 is for CH3 symmetric vibration. The 
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peaks at 1136, 845 and 725 cm- 1 correspond for antisymmetric C-0-C vibration, 0-0 
stretching and C-C stretching vibrations, respectively. 
X-ray Diffraction pattern of MCM was obtained at a scan rate of 0.75 deg/min. in the 
range of 0.00-45.00 2-8 at room temperature ( 19.00 ± 2.00°C) (Figure 11 A). The vehicle 
showed amorphous behavior under given experimental conditions. X-ray studies was 
also conducted for sheared MCM (Figure l lB). The DSC results Table V, demonstrated 
that MCM showed unstable conditions when it was heated up and cooled 3 times. 
Therefore, X-ray pattern of MCM subjected to 3 heating cycles was taken (Figure l lC). 
Like shear, heating did not caused a detectable change in the structure of the vehicle 
within the measurable limits of the instrument. 
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4.2 CHARACTERIZATION OF THE DRUG 
DQAJC used in this study is a peptide derivative. All the relevant properties of the drug 
were discussed in Sections 1.2 and 1.3. The amorphous form of the drug that was used in 
the study had 0.03 mg/mL water solubility and 400 mg/mL MCM solubility at 21°C. It 
decomposed above 200°C. In addition to these known properties, characterization of the 
drug by using DSC, Ff-IR and X-Ray diffraction was conducted in order to understand 
changes occurring in the system. 
Amorphous DQAIC is a white, powder which has average mean particle size of 5 µm 
(Figure 12). It does not refract under polarizing light. 
The moisture content of the drug was determined using the titration technique explained 
in Section 3.3.2.7. The average of three moisture content was 1.135± 0.002 %w/w. 
The results of thermodynamic screening of DQAIC is given in Figure 13. The heating 
curve of DQAIC provides a sharp endothermic peak at 106.4° ± 001.5°C. From the 
cooling curve, the glass transition temperature was calculated as 104.9°C. Enthalpies 
tabulated are given in Table VII. 
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Figure 12: Microscopic Image of Powder DQAIC with 20 x 25 Magnification at 
19.00 ± 2.00°c. 
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Table VII: DSC Performance of the Drug Scanned Between 20°-150°C; Heating 
and Cooling Curves 
Heating Cooling 
Cycle Temperature(°C) Enthalpy (mJ/m) Temperature(°C) Enthalpy (mJ/m) 
106.4 8.1 l 04.9 -82. l 
2 105.6 2.3 106.2-82.5 
3 105.4 2.5 l 06.2-81.4 
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Figure 14: X-ray Pattern of DQAIC Taken at 0.75 deg/min in a 2-8 Range of 1-70 
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X-Ray Diffraction pattern of the drug is shown in Figure 14. The little peak occurred at 
32 2-0 may be from the result of crystalline impurities or a minute portion of the drug 
that is crystallized. 
FT-IR spectrums along with Raman spectrums were obtained as explained in section 
3.3.2.3. 0-H and N-H stretching were obvious between 3500 and 3000 cm·' appeared as 
a broad band (Figure 15). The bands obtained at 2924 and 2863 cm·' are representative 
of C-H aromatic rings stretching. The strong peak appeared at 1659 cm·' can be for C=C, 
C=O and C=N stretching. N-H bending can be seen at 1570 cm·'. Finally, C-H, and 0-H 
bending can be seen at between 1524 and 1456 cm·'. 
In the Raman spectrum of the drug, Figure 16 a weak peak for 0-H stretching vibration is 
found at 3064 cm·'. -C-H stretching vibrations are seen at 2931 cm·'. The peak at 1674 
cm·' corresponds to C=O vibration. The region between 1600 cm·' and 1435 cm·' 
exhibits -CH2 and CC aromatics vibrations. The strongest peak at 1384 cm·' shows that 
the compound has mainly aromatic C=C structures. The peak at 1008 cm·' demonstrates 
C-C aromatic vibrations. C-0-C symmetric vibration peak can be seen at 776 cm·' as one 
of the strongest peak of the spectrum. 
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Overall, the drug used in this study is an amorphous drug. Therefore, it is in metastable 
state. Any processing condition may affect its morphological properties. The Ff-IR and 
Raman studies, Figure 15 and 16 demonstrated that it can form hydrogen bonds, Van-der 
Waals as well as hydrophobic bonds. It may easily interact with suitable solvents. 
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4.3 CHARACTERIZATION OF THE DRUG SOLUTION IN MCM 
In order to determine solvent- solute interaction, the rheological properties, DSC, Fr-IR 
and X-Ray of the 20% (w/w) DQAIC solution in MCM were investigated. This 
concentration is the therapeutic concentration that is used per capsule. 
4.3.1 Rheological Characterization 
Figure 3 demonstrates that the viscosity of the drug solution remained Newtonian 
although the viscosity increased from 83 cP to 41 l cP at 25°C. The results demonstrate 
no changes in viscous pattern between 1-500 I/sec shear rate. Creep measurements 
(Appendix I, Figure 9) obtained showed there is no elastic component in the system. 
Both MCM and 20% (w/w) drug showed purely viscous behavior. The viscous modulus 
(G"), elastic modulus (G') and complex viscosity (Tl*) of the solution and MCM were 
also studied with an oscillatory viscometer. The strain sweep, Figure 17, shows that all 
rheological parameters of the drug solution and MCM are linear in a strain range of 0.1-
10. Therefore, any strain values between 0.1 and 10 can be used to carry out frequency 
and temperature sweeps. In the strain sweep experiment, G" of the drug solution was the 
highest with a value of 12 dyne/cm2 • There was hardly any elasticity, G' value was 
found as O. l dyne/cm2 and 11* at the zero shear was 380 Poise. 
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9.1 
Frequency sweep carried out in a frequency range of 0.1-0.5 Hz demonstrated an 
interesting phenomenon (Figure 4, Section 4.1.). Although the solution was characterized 
as a viscous system, and in a rotational viscometer, the rheogram indicates a Newtonian 
behavior, the oscillation dependent increase in the viscous modulus (G") demonstrated a 
structure built up in the system. The same property, in much lesser magnitude, exists in 
MCM, Figure 4. The findings demonstrate that, shear dependent intra molecular 
interaction is somewhat present in MCM, but increased greatly by the presence of the 
drug. 
The temperature sweep (Figure 5) demonstrated that all the rheological parameters (G', 
G" and Tl*) decrease as the temperature increases. Among the all parameters, G" of the 
solution was found to be highly temperature dependent. The decrease in G" between 4°C 
and l0°C is linear, but it is the most critical between l0-40°C. The change in G' value of 
the solution and in all measured rheological components of MCM is much less critical 
again demonstrating the presence of DQAIC in MCM increased the temperature and 
shear dependence greatly. 
Overall, G" was found to be a representative of the structural changes occurring in the 
drug solution and may be used as a critical parameter to investigate various experimental 
factors and to demonstrate gelling potential of a formulation. 
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4.3.2 Solution Morphology and Physico-Chemical Characteristic of DQAIC 
DSC of 20% (w/w) DQAIC studied between 20°C and 65 °C did not show any traces in 
during heating and cooling, Figure 18. DSCs of the solution obtained between -70°C and 
150°C are given in Figure 19. Since the drug is amorphous, DSC of only MCM and drug 
solution was compared (Figure 19 A and B). The difference in MCM in the presence of 
DQAIC occurred is the peak of the monoglyceride appeared at 21°C. It is moved to 
18.69°C indicating a weakened interaction of the chains. The melting point of 
diglyceride shifted from -l.37°C to -4.86°C indicating relatively weakened structure. In 
the solution form, the enthalpy of both monoglyceride and diglyceride are decreased as 
expected. Those may indicate an interaction of the drug with -OH groups of the vehicle. 
The presence of the drug also influences crystallizing ability of MCM as impurity. 
In the drug solution, an insignificant peak occurs in the immediate left cf the 
monoglyceride peak of MCM. In the presence of DQAIC, this peak is increased in 
intensity and the shape. It might indicate an interaction of the drug with component that 
is present in minimum amount in MCM. 
A FT-IR difference spectrum was generated by subtracting the MCM spectrum from the 
solution spectrum in order to compare both spectra clearly because the peaks of MCM are 
very strong (Figure 20). In the spectrum of the solution, the region 
54 
t 
-~ a 
... 
~ 
-1875 
.c 
--2250 0 
~ 
~ 
~ 
u 
C"'-l 
Q 
-2625 
·- --- ' ""'" ...... - ........ ' .,.,,,. 
~----- ""' 
...... ----------..... ,-- ,,, 
--
30 40 50 
TEMP C (Heating) 60 
' \'. 
' 
Figure 18: DSC Traces of 20% DQAIC Solution During Heating(-) and Cooling 
(----) Between 20°C and 65°C at a Rate of 0.33°C/min 
55 
(A) 
t 
-~ 
s 
a.. 
~ 
.c 
-
3750 
~ -500 
~ 
~ 
:t 
u 
rJl 
Q 
-4750 
-2!5.83 c 
-3498 uW 
-0.79 c 
-4-467 uW 
21. 76 c 
-727!5 uw 
-9000L------------A-------------._ __________ _J.. __________ ___, 
(B) 
.: 
s 
a.. 
~ 
.c 
-0 ;.< 
-40 
~ -3.5 
~ 
:t 
u 
IJ') 
Q 
-6.75 
' 
-20 
-26.03 c 
-3.!57 aw 
0 TFMP C (Heat ina) 20 
5. 0 •J/11g 13. 4,.. /Ilg 
- - - - -_ .e. !5 aJ/11g ...... 
-4.!5!5 c 
-3.71 mW 
--- "" 
18.89 c 
-!L42 mW 
40 
-10L-----------L------------li.-------------I.------------' 
-40 20 0 20 40 
- TEMP C (Heating) 
Figure 19: Comparison of DSC of MCM (A) and 20% (w/w) DQAIC solution (B):) 
between -70°C and 150°C 
56 
between 3600 cm· 1 and 3000 cm· 1 exhibits 0-H and N-H stretching. This band is similar 
to one that was seen in the drug powder (Figure 15). The only differences in this region 
is the appearance of an extra weak peak at around 3600 cm· 1 in the spectrum generated by 
the solution of the drug. This difference shows that there is little increase in the 0-H 
bonding between the drug and MCM. The other difference observed is the weak peak at 
around 2800 cm· 1 which corresponds to C-H stretching in the solution spectrum. The 
weak band seen at around 1700 cm· 1 can be due to C=O stretching which was not seen in 
the drug molecule. Other traces such as the one at 1667 cm·1 for C=C. C=O and C=N 
stretching and at 1500 cm· 1 for C-H and 0-H bending are the same peaks seen in the 
spectrum of the drug. 
There were no changes in Raman spectra of the solvent, drug and the drug solution, 
(Appendix I, Figure 14). 
The particle size determination was also carried out on the solution using Dynamic Light 
Scattering (DLS). As explained in Section 3.3.2.5, first zero shear viscosity was found 
from the frequency sweep. Complex viscosity (Tl*) with a value of 338.92 cP was 
accepted as a zero shear viscosity. Particle size of the solution was found to be 8.85 ± 
0.30 nm with polydispersity of 0.218. The data indicate that the drug at 20% 
concentration is not a true solution. 
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4.4 CHARACTERISATION OF SOLUTION AFI'ER SHEAR 
The DQAIC solution in MCM begins to develop gelled cores after being sheared 6 hours 
at 3000 rpm, and gelled completely within 12 hours turning into an opaque-cremish semi-
solid structure. Table VIII summarizes the microscopical changes taking place in the 
solution during 12 hours shearing and Figure 21 shows the microscopic appearance of the 
gelled solution. 
4.4. l Rheological Investigations 
A frequency sweep of the gelled solution , Figure 22, showed that all the rheological 
parameters were increased. The increased elastic modulus (G') is indication of gelling 
occurred after shear while it was almost zero before shearing of the solution. The system 
changed from Newtonian to pseudoplastic behavior as indicated by decreasing complex 
viscosity. The effect of shearing time on G" of solution and MCM is also shown in 
Figure 23. G" or other rheological parameters of the solution increased with time, while 
G" of MCM did not change. 
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Table VIII: Microscopic and Visual Observation of the Drug Solution During 
Shear 
Sample 
The drug solution in MCM pre-sheared 
The drug solution in MCM sheared 3 hr 
The drug solution in MCM sheared 6 hr 
The drug solution in MCM sheared 9 hr 
The drug solution in MCM sheared 12 hr 
Comments 
Yellow, viscous, clear liquid , clear under 
the microscope 
Yellow, viscous, clear liquid, nothing seen 
under microscope 
Yellow, viscous translucent liquid , clear 
under the microscope 
White, translucent semisolid, cloudy 
background, extended fibrils 
White, opaque semisolid, cloudy 
background, more distinguished fibrils 
Figure 21 : Microscopic Image of DQAIC Solution After Shearing 12 hr at 25 x20 
Magnification under Cross Polar. 
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4.4.2 Morphological and Phsicochemical Characterization of the Gelled DQAIC 
Solution 
Tables IX and X demonstrate the DSC traces of the non-sheared and sheared (gelled) 
sample. The samples were subjected to three heating and cooling cycles. Comparison of 
enthalpy before and after shear shows an increase in the enthalpies of di- and triglyceride 
peaks after shearing of the solution. However, disappearance of these differences after 
second and third heating cycle may be due to moisture uptake during shearing of the 
solution. Overall, there are no significant differences in DSC results except little shifts 
appeared in melting point peaks, Figure 24. 
Figure 25 shows FT-IR spectra of comparison of non-gelled and gelled samples. The 
band between 3600 cm- 1 and 3000 cm- 1 which exhibits an 0-H and N-H stretching 
which is much broader in the spectrum of sheared sample than that of the pre-sheared 
one. In addition, a shoulder appeared at 3548 cm·' and an insignificant shoulder at 3220 
cm·' in the non-sheared sample became significantly high in the sheared solution. The 
other major difference is seen at 1520 cm· 1• This peak is stronger in the pre-sheared 
sample than in the sheared one. This shows that the shearing causes a decrease in N-H 
and 0-H bending. All other bands are identical in the both spectra. Raman spectrums of 
the formulation before and after shear were also used for comparison of both samples 
(Appendix I, 15). However, no shear induced differences were seen in these spectra. 
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Table IX: Effect of Shear on the Thermodynamic Properties of the Solution as 
Determined by Heating Cycles Between -70°C and 150°C 
First Heating Second Heating Third Heating 
Peak Temperature AfI Temperature AfI Temperature AfI 
(OC) ml/mg (oC) ml/mg (oC) ml/mg 
Solution -26.15 12.7 -25.13 17.0 -24.56 19.1 
gel (endo) -24.24 19.5 -24.56 16.7 -22.52 16.9 
Solution -21.10 -41.2 -17.25 -36.4 -17.67 -37.2 
gel(exo) -18.91 -39.7 -17.03 -43.4 -16.42 -46.6 
Solution -4.52 7.1 -4.86 5.8 -4.82 6.7 
gel (endo) -3.58 10.9 -4.52 4.1 -4.2 4.5 
Solution 18.97 12.7 18.69 8.9 18.96 6.6 
gel (endo) 19.89 11.5 19.61 9.2 20.55 5.7 
Table X: Effect of Shear on the Thermodynamic Properties of the Solution as 
Determined by Cooling Cycles Between -70 and 150°C 
Temperature (°C) ~H (mJ/mg) 
First Cooling, solution -42.45 -30.3 
First Cooling, gel -41.82 -31.0 
Second Cooling, solution -43.10 -29.6 
Second Cooling, gel -42.13 -29.5 
Third Cooling, solution -43.37 -29.5 
Third Cooling, gel -42.21 -30.0 
64 
t 
.~ 
E 
-
~ 
.c 
-0 
,.. 
2250 
l< -500 i;i;J 
I 
I 
I 
I 
I 
I 
I 
I 
I 
~ 
::t 
u 
rJ'). 
Q 
-3250 I 
\ I 
.I 
---------
-soooL-~~~~~-'--~~~~~--1~~~~~~....!-~~~~~--' 
-50 -25 0 25 
TEMP C (Heating) 50 
Figure 24: DSC Heating Curves of Non-sheared (-) and Sheared (----) Samples 
Between -70°C and 150°C 
65 
= 
.:: 
-9~L"9U. 
= 
-0 ,,, 
~ 
0 ,..; 
-0 0 -;' 
..... s 
i:J 
~ 
-~ 
-L9"99£• c:l 
-Vl:"llZ:ll'• ~ z:s·vc;v~ 10 c. 
<;5·00<;• -~ s IW<;Z:<;~ ~ 
rJ:J 
z:s· as· ~ 
~z: · gz:H ~ Sl:H ~ 
I 
Qj 
~ 
~ 
r o_ = _o ..... ~ Oo 
-
NE ~ I .:!. 
-~v9HZ: I Q; ~ 
.0 
-E c. 
:;;J s c 
~ ~ 
> rJ:J 
"' 3: ~ 
8 ~ 
Ii) ~ N OJ) 
I 
= 0 
z 
._ 
I 
0 
I e,z I. 
Z:I: 9Z:6Z: a<>·asz: 
-
-8 i:J ~ c. ..., 
rJ:J 
a! 
-I E--
~ 
~v·vc;1:c 
._ 
0 
8 = 0 
Ii) ,,, 
..., .i: 
e,z 
c. 
s 
0 
u 
ti) 
M 
~ 
<O ""'. N 0 I. 
= bJ) 
a::iueq.iosqv ~ 
66 
The gelling phenomenon was also followed by the X-ray diffraction, Figure 26, 
demonstrates those changes. Shearing causes structure development in the system and 
gel is characterized with a small peak that occurred at 20 28. 
The water content of MCM and the 20% DQAIC solution before and after shear was 
analyzed. The moisture content of MCM before shearing at 50% RH is 0.464 ± 0.024 % 
(w/w), which was increased to 1.664 ± 0.037 % (w/w) after shear. The drug solution has 
0.727 ± 0.025 % (w/w) moisture content before the shear, which increased l. l 35 ± 
0.024% after shearing. 
Overall, the increase in 0-H, N-H stretching and the decrease in 0-H and N-H bending 
from FT-IR studies shows that there are conformational changes in molecular structure of 
the system which was conformed further by X-ray studies. Shearing also induced 
moisture uptake of the solution. 
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Figure 26: X-Ray Diffraction of MCM (4), 20 % DQAIC Solution Before Shear (3), 
After 6 hour Shearin2 (2) and 12 Hour Shearing (1) 
4.5 DETERMINATION OF THE INDIVIDUAL VARIABLES THAT AFFECT ON 
GELLING 
4.5.1 Combined Effects of Shear and Temperature 
In order to investigate the effect of the shear on the gelling properties of the system, the 
formulation was subjected to 500 rpm, 1500 rpm and 3000 rpm shear rates using 
Silverson lAR high shear mixer, and the gelling time of the formulation was observed, 
Table XI. As it can be seen from the results, shear induces gelling phenomenon of the 
drug solution in MCM. Further the formulations were sheared at 25°C, 40°C, 60°C and 
80°C, Table XI. Shearing the formulation at 40°C instead of 25°C induces gelation of the 
formulation. However, at 60°C the solution gels at longer periods than those sheared at 
25°C and 40°C. When the temperature was increased up to 80°C, the solution has not 
formed a gel but a color change from yellow to brown was observed during shear at this 
temperature after 24 hours. A chemical reaction or decomposition may occur at this 
temperature. 
4.5.2 Effect of Humidity 
The formulation was subjected to shear at 50 % and 30 % Relative humidity (RH) to 
investigate the effect of the environmental humidity. Little increase observed in the 
gelling time of the solution at lower humidities, Table XI. 
69 
Table XI: The Variables that Affect on Gelling Time of the Formulation 
Study Conditions Gelling time (hr) 
500 rpm, 25 cc, 50% RH 25.0 ± 2.0 
1500 rpm, 25 cc, 50% RH 18.0 ± 2.0 
3000 rpm, 25 cc, 50% RH 10.0± 2.0 
25 cc, 3000 rpm, 50 % RH 10.0 ± 2.0 
40 cc, 3000 rpm, 50 % RH 6.0 ± 1.0 
60 cc, 3000 rpm, 50 % RH 20.0 ± 2.0 
80 °C, 3000 rpm, 50 % RH did not form a gel 
50% RH , 3000 rpm, 25 cc. 10.0 ± 2.0 
30 %RH, 3000 rpm, 25cc 12.0 ± 1.0 
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4.5.4 Effect of Storage Time 
The formulation as well as MCM alone was left for a month at different conditions 
described in Section 3.3.2.6 to investigate gelling tendencies of the formulation upon 
storage. Viscous modulus was obtained from strain sweep as a representative of a 
rheological parameter every 7 days after equilibrated for 12 hours at room temperature. 
Figure 27 shows G" values vs. time at two different humidity levels ( 40 % and 60%) at 
25°C. As it can be seen from the Figure 27 there is no significant change in G" values 
after a month. Figure 28 shows G" values vs. time for the samples that kept at 4 °C , 25°C 
and 50°C for a month. There is only small amount increase in G" (from 11.975 dyne/cm2 
,, 
to 13.586 dyne/cm-) when the sample was kept at 50°C after 4 weeks. 
4.5.5 Effect of The Drug Concentrations 
Even though formulation studied contains 20% drug, during testing, concentration has 
been demonstrated a significant effect on the gelling tendencies of the formulation. The 
effect of drug concentration on the gelling phenomenon was investigated by preparing 0, 
2, 5, 7, 10, 12, 15, 17, 20, 22, 25% (w/v) DQAIC solutions and subjecting the solutions to 
shear as described in Section 3.3.1. The solutions at 15% (w/v) or below concentration 
did not form a gel after being sheared for 3 days at 3000 rpm, using a Silverson L4R 
homogenizer. 
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Figure 27: G" profiles with time for MCM and 20% 
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28 
In order to evaluate the structure of the system at different concentrations, rheological 
parameters were measured for each concentration. Zero shear values were obtained at 
25°C. Complex viscosity (Tl*) from frequency sweep was accepted as zero shear 
viscosity and plotted against concentration, Figure 29. Up to 10% (w/v) concentration, 
the viscosity increases gradually with increasing concentration. Between 10-15% (w/v), 
viscosity increases more by increasing concentration. This region may be accepted as the 
region where gelling starts until it reaches the critical concentration ( 16% w/v) where it 
becomes entirely shear sensitive. 
In order to investigate further, particle size of the solution at each concentration was 
determined. The vehicle and 2, 5, 7% (w/v) solutions do not have any particles. When 
the drug concentration is increased up to 10% (w/v), particles begin to appear and particle 
size increases as the concentration increases, Figure 29 and Table XII. The effect of 
shearing time on particle size also investigated showed that shear causes particle growth, 
Figure 30. Before shear, 15% (w/v) solution demonstrated an average particle size of 4.7 
nm. This increased to 9.5 nm after 12 hours shearing at 3000 rpm. Similarly the initial 
particle size of 8.8 nm of 20% (w/v) solution increased to 19.5 nm with shear. Those 
particles disappear at 80°C whereas they increases at 40°C compared to those measured at 
25°C from 8.8 ± 0.3 nm to 12.5 ± 0.5 nm. The increasing particle size with increasing 
drug concentration may be one of the reasons of gelation. 
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Table XII: Particle Size Measurements of DQAIC Solution at Different 
Concentrations at 25°C 
Concentration(% wt/v) 
10 
12 
15 
17 
20 
22 
25 
0 200 
Particle Size (nm) Polydispersity 
2.6 ±0.3 
3.3 ± 0.4 
4.0±0.2 
5.2 ±0.4 
8.8 ±0.3 
9.3 ±0.4 
10.90±0.8 
400 
0.509 
0.408 
0.211 
0.383 
0.218 
0.233 
0.373 
J ~Particle Size of 15% 
1 (w/v) Solution 
I 
- Particle Size of 20% 
(w/v) Solution _ 
600 800 I 
Shearing Time (minute) 
Figure 30: Effect of Shearing Time on Particle Size of 
15% and 20% (w/v) Solutions at 25°C 
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DSC of 10 % solution, where gelling does not occur and of 25 % at which gelling occurs 
were compared, Figures 31 A and B. The enthalpy values of the endothermic and 
exothermic peak are given in Table Xill. The DSC shows that the melting points of 
triglyceride components are identical for both solutions. The exothermic peak which is 
an indicative crystallization of diglyceride has a shoulder which is more distinguished in 
25% (w/v) solution. The third peak shifted towards left at 25% (w/v) concentration. It is 
weakened at this concentration providing enthalpy of 4. 7 mJ/mg, half of 10% solution. 
Insignificant peak of MCM that appeared around at 11 °C (Figure 7), was increased as the 
drug concentration was increased. This became visible in the 20% solution before shear 
(Figure 198). The enthalpy of this melting peak was increased from 10% to 25% from 
4.4 mJ/mg to 12.44 J/mg, Figure 31. However, shearing has not changed the magnitude 
of it. It is obvious from Figure 31 A, the drug concentration has significant effect in the 
presence and magnitude of this peak. These results may indicate that, the drug may 
interact with one of the vehicle components which is present in a small amount. The 
interaction between water or glycerin and the drug solution was shown by addition of 
2.4% water or glycerin to 20% DQAIC solution. DSC of these mixtures Figures 32 A 
and B may suggest this possibility. 
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Table XIII: DSC Traces During Heating Curve of the Drug Solution in MCM at 
10% and 25% (w/v) Concentrations 
Peak* % (w/v) Temperature (°C) Enthalpy (mJ/mg) 
10 -27.07 10.5 
1 25 -26.22 11.1 
2 10 -21.54 -44.4 
2 25 -21.03 -42.4 
3 10 -3.11 8.7 
3 25 -5.42 4.8 
4 10 9.60 4.4 
4 25 12.44 12.8 
5 10 19.97 25.2 
5 25 18.54 8.6 
* Peaks numbered in italic form are for 25% (w/v) solution 
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4.5.6 Reversibility of Gelling Phenomenon 
Ff-IR spectra revealed that, in the gelled samples slight changes occurred at between 
3000 cm· 1 and 3600 cm· 1 regions indicating that the gelling phenomenon seems to be 
predominantly physical in nature. The gelled solution was heated up to 65°C, it reverted 
to a clear solution. Ff-IR spectrum and rheological parameters of reverted solution were 
obtained. Frequency sweep tests showed (Figure 33 A, B, C) that rheological parameters, 
G', G" and 11* , of pre-sheared and heated solutions were same, while there is a 25 fold 
increase in the G" of sheared sample. Ff-IR spectrum (Figure 34) of the sample also 
shows that there is no differences between pre-sheared sample and heat recovered sample. 
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4.6 POSSIBLE EXPLANATIONS FOR THE GELATION 
Micelles formation and molecular rearrangement were postulated mechanisms for the 
gelling phenomenon of the formulation. The phenomenon is concentration dependent. 
The solution reaches saturation at a concentration of 17% (w/v) and addition of drug 
beyond this level may increase particle formation in presence of impurities such as 
glycerin and water in the vehicle resulting in drug-drug aggregation. These formed 
particles can act as gel nuclei. With increased drug concentrations, the particles also 
become larger providing higher possibility of interaction upon shear. Shear causes 
particle growth then these particles become continuous phase that may result in phase 
transition. These particles can be temperature sensitive new metastable form of the drug. 
Because they become larger at 40°C compare to those at 25°C and disappear at 80°C. 
Gelling forms faster at 40°C than at 25°C and did not occur at 80°C. These results show 
that those formed particles can be the reason of gelation. 
One other explanation can be given as follow: Since the vehicle has surfactant properties, 
it can form micelles. At low concentrations of the drug, these micelles may be spherical. 
However, at high drug concentrations, they may change to stringlike micelles. Long 
strings may easily entangle upon shear and present structure as seen in Figure 20. The 
micelle formation can be analyzed further using Deuteriated NMR, short angle X-Ray 
Scattering and Cryogenic electron microscopy (Cryo-TEM). 
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These studies also shows that shear somewhat induces the weak hydrogen bonding 
between the molecules resulting in molecular rearrangement. Therefore, system tries to 
arrange itself resulting in phase transition. 
4.6. l Studies to Correct Gelling 
Different vehicle grades were also evaluated. These grades are namely MCM(D), which 
contains higher monoglyceride component, and PG-8, containing propylene glycol fatty 
acid (C8 - C 10) esters instead of glyceride. These vehicle grades are explained in section 
3. 1.1. The same gelling phenomenon was observed with these vehicles. Only the gelling 
time was delayed (2-3 hr) with MCM(D). Therefore, increasing of mono-ester 
component has somewhat advantage in terms of minimizing the gelling tendency of the 
formulation since the solubility of the drug increases as the monoglyceride component 
mcreases. 
Since gelling is temperature dependent, the effect of temperature on the rheological 
parameters of these formulation correlated using Arrhenius equation as follows: 
In G" = In A + (E;/R) l!f .. .. .. ... .. .. .. ... .. .. .. ..... ...... .. ............... ........ ...... ... ........ ..... ..... ...... ..... . (5) 
where G" is viscous modulus used to replace viscosity, A is a constant depending on the 
molecular weight and molar volume of the liquid, T is absolute temperature , R is gas 
constant and Ea is the activation energy. 
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According to Arrhenius equation, the slope of lnG" vs. lff gives EJR. A temperature 
sweep between 4 °C and 80°C was carried out using the rheometer and lnG" vs lff was 
plotted for each formulation (Appendix I, Figure 16-18). The slopes were found and the 
activation energy was tabulated with their gelling time for these formulations , Table XIV 
and Figure 32. As it can be seen from the results the higher activation energy of a 
formulation, the longer the gelling time. Therefore, the calculation of activation energy 
can be helpful to characterizing gelling tendency of a proposed formulation. 
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Table XIV: Gelling Time and Activation Energy for 20 % DQAIC Solution with 
Different Vehicles 
Formulation 
PG-8 + 20 % drug 
MCM + 20% drug 
MCM(D) + 20 % drug 
MCM + 20 % drug + PVPK30 
12500 I 
' 
11500 i ~ 
I 
0 I 
E 10500 L 
----... ! 
0 I u 
9500 t ~ < 
8500 ~ 
I • 
7500 - -
5 8 
Gelling Time Activation Energy 
(hr) (caVmol) 
7± 1.0 8108 
10± 2.0 10604 
11± 2.0 10564 
15± 1.0 12195 
y = 492.08x + 5078.8 
R2 = 0.9282 
--- - ·-- - - - - - --
11 14 17 
gelling time (hr) 
Figure 32: Correlation Between Activation 
Energy and Gelling Time of a Formulation 
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Y. CONCLUSION 
Rheological studies showed that the gelling tendency of the system is related to its 
molecular rearrangements rather than its flow properties. Viscous modulus (G") among 
all of the rheological parameters was found to be a good representative of changes 
occurring in the system. The increased rheological parameters in sheared sample is the 
sign of structure build up in the system. 
Shear induced hydrogen bonding between drug-drug and/or drug-vehicle was 
demonstrated by a significant increase in absorbance at 3300-3600 cm- 1 band region by 
Fr-IR. Fr-IR studies also showed that there was no major chemical interaction during 
shear of the formulation. The slight polymorphic changes detected by X-ray diffraction 
show that some molecular rearrangement may occur during shearing. 
Shear rate used is an important factor. As it increases, the gelling tendency increases. If 
the shear is combined with other factors such as temperature and humidity, the gelling 
tendency becomes more critical. Especially, temperature has an important effect on 
gelling phenomenon. As it increases up to 40°C, gelling ocCL:r ~ faster. If shearing was 
carried out above 60°C, gelling occurs over a longer time period. 
During stability measurements, no time effect was observed at 4 °C, 25°C and 50°C and 
40% and 60% relative humidities. However, time is an important factor if it is combined 
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with shear because gelling of DQAIC solution in MCM is a shear induced time dependent 
behavior. 
The gelling tendency of the formulation was also found to be concentration dependent. 
Placebo and the solutions at 15% (w/v) concentrations and below did not form a gel after 
shearing for a prolonged period of time. The increased particle size above 10% (w/v) 
concentrations suggested that the system may not a true solution. These temperature, 
shear and concentration dependent particles can be a temperature sensitive physical form 
of the drug which causes gelling. 
The gelling were found to be reversible by heating the gelled sample up to 65°C. 
In order to minimize the gelling phenomenon, the solution should be prepared at very low 
shear rates. The energy given by heat should be higher than the energy given by shear, so 
that gelling can be avoided. If possible, all processing should be conducted at or above 
60°C at low humidity levels. 
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Figure 15: FT-Raman Spectrum Of 20 % DQAIC Sheared Solution At -lcnf 1 
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Figure 16: In G" vs 1/T for the formulation contains 
PG-8 and 20 % drug obtained with 6 cm Parallel Plate 
and 1 mm gap between 4°C and ao0c 
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Figure 17: In G" vs 1/T for the formulation contains 
MCM (D) and 20 % drug obtained with 6 cm Parallel 
Plate and 1 mm gap between 4°C and ao0c 
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Figure 18: In G" vs 1/T for the formulation contains 
MCM and 20 % drug obtained with 6 cm Parallel Plate 
and 1 mm gap between 4°C and ao0c 
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